SAMHSA Bans Federal Funding for Fentanyl Test Strips and Clean Syringes

On April 24, 2026, SAMHSA sent a letter to all federal grant recipients: federal dollars can no longer be used to distribute fentanyl test strips, xylazine test strips, medetomidine test strips, or sterile syringes to the public. The letter cites an executive order signed by President Trump in July 2025.

What Was Cut

The ban covers the core supply chain of street-level overdose prevention: the strips that tell someone in real time whether what they are about to use contains a lethal adulterant, and the syringes that prevent HIV and hepatitis C transmission. Since January 2026, the administration has terminated approximately $1.7 billion in addiction and overdose prevention funding. The Kentucky Harm Reduction Coalition lost a $400,000 grant and had distributed 48,465 fentanyl test strips in just the first quarter of fiscal year 2026.

The Contradiction

Fentanyl test strips are not paraphernalia under the laws of 45 states and Washington D.C. The SUPPORT Act — passed with bipartisan support in 2018 and reauthorized in 2025 — explicitly protected their use and federal funding. The administration position puts executive policy in direct conflict with an act of Congress.

Why This Matters for People in Recovery

Access to harm reduction tools is not in conflict with recovery — it is often the bridge that keeps someone alive long enough to reach it. If you are looking for naloxone, test strips, or syringe access and federal programs in your area have lost funding, community health centers and many pharmacies continue to offer these resources independently. Find harm reduction and treatment resources near you.